Project Grant R21DA065027
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston Children's Hospital a $489,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 1, 2025 and concluding May 31, 2027. This research initiative develops and validates remote oral fluid testing procedures to assess cannabis non-use as a key outcome measure in clinical trials targeting younger adults aged 18-30 years with cannabis use disorder (CUD). The project...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded $709,085 to the University of Colorado-Denver for an implementation research trial commencing April 1, 2026, and concluding January 31, 2031. This project delivers implementation facilitation services and clinical intervention support designed to expand in-hospital opioid treatment program (OTP) intakes for hospitalized patients with opioid...
- Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $385,638 to The Regents of the University of Colorado (University of Colorado-Denver) under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 1, 2025, with a completion date of August 31, 2028. This research award funds a three-year neurobehavioral investigation titled "Cannabinoid Tolerance Across Neurodevelopment: Disruption of Value-Driven Behavior and Prevention Through...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $730,649 Project Grant to the University of California, San Diego, effective May 1, 2026, through February 28, 2031. The project, titled "The Acute Effects of Cannabis Use on Parenting," delivers research services and data collection focused on understanding how cannabis use impacts parenting behavior among regular users with young...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Vermont & State Agricultural College a $387,291 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning March 1, 2026 and concluding December 31, 2030. The project will deliver longitudinal neuroimaging research and analysis to delineate developmental windows of vulnerability to cannabis exposure and examine causal relationships between cannabis use,...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai a $507,000 Project Grant, effective September 1, 2025 through May 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This award supports research investigating the epigenetic basis of tetrahydrocannabinol (THC) consumption and cannabis use disorder (CUD). The project utilizes a translational preclinical model of volitional THC consumption in animal...
- Federal Grant Award Summary The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a Project Grant totaling $3,227,517 to the University of Colorado-Denver on September 20, 2025, under the Alcohol Research Programs (CFDA 93.273). The research project, which extends through August 31, 2029, investigates the effects of full-spectrum cannabidiol (CBD) on alcohol consumption and alcohol use disorder (AUD) phenotypes with implications for precision medicine approaches. The study...
- This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a $465,250 Project Grant effective September 1, 2025 through August 31, 2027 under the Drug Use and Addiction Research Programs (CFDA 93.279). This research project will conduct a double-blind, placebo-controlled human laboratory study to assess pregnenolone's potential as a treatment for cannabis intoxication symptoms. The research aims to evaluate whether pregnenolone, a...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $719,720 to the University of Colorado-Denver under the Drug Use and Addiction Research Programs (CFDA 93.279) for a project period from May 1, 2025 through March 31, 2028. This Project Grant supports the development of computational modeling tools and open-source software for the neuroscience research community to analyze mouse forelimb movements in the context of healthy and injured motor networks. The primary...
The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded $248,201 to The Regents of the University of Colorado-Denver on April 15, 2026, for a two-year research project concluding March 31, 2028. The University of Colorado-Denver will conduct a rigorous validation study assessing the performance of cannabis detection devices utilizing two innovative approaches: breath sampling and ocular (pupil dynamics) assessment methods. The study will evaluate the reliability, repeatability, and predictive validity of two commercially available or near-market breath sampling devices and two ocular devices to detect recent cannabis use during the acute impairment window—a critical gap in current detection capabilities. The research will employ a within-subjects observational design with 45 participants to accomplish three primary objectives: (1) test the repeatability of cannabinoid measurements in breath samples and pupil response assessments; (2) determine the duration of detectable cannabis effects over a 4.5-hour post-use observation period; and (3) evaluate the joint predictive validity of both detection methods. The project directly addresses public safety concerns related to cannabis-impaired driving by developing objective, non-invasive, and portable detection methods that overcome limitations of existing blood and urine biomarker approaches. Findings will refine detection protocols and inform industry standards for cannabis impairment assessment.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $248.2k | 4/14/26 |